Pandox AB (PNDX.B) AI Stock Analysis

• Market Cap: kr36.78B
• Dividend Yield: 2.24%
• Average Volume (3M): 204.79K
• Price to Earnings (P/E): 18.1
• Beta (1Y): 0.70
• Revenue Growth: 2.86%
• EPS Growth: N/A
• Country: SE
• Employees: 1,505
• Sector: Real Estate
• Sector Strength: 53
• Industry: Travel Lodging
• EPS (TTM): 3.17
• Shares Outstanding: 119,603,000
• 10 Day Avg. Volume: 102,414
• 30 Day Avg. Volume: 204,786
• PEG Ratio: -0.06
• Price to Book (P/B): 1.07
• Price to Sales (P/S): 5.02
• P/FCF Ratio: 44.69
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 67 Neutral
• Price Target: kr205.00 ▲(10.45% Upside)

Pandox AB's overall stock score is driven by strong financial performance, particularly in revenue growth and operational efficiency. The technical analysis supports a positive short-term trend, while the valuation is reasonable with a moderate P/E ratio and a decent dividend yield. However, cash flow challenges and declining net profit margins are areas of concern that slightly temper the overall score.

Positive Factors

Revenue Growth

Consistent revenue growth indicates a strong market position and effective business model, supporting long-term financial stability.

Operational Efficiency

Strong operational efficiency through healthy margins suggests effective cost management and robust business operations.

Stable Balance Sheet

A stable balance sheet with moderate leverage supports financial resilience and the ability to invest in growth opportunities.

Negative Factors

Declining Net Profit Margins

Decreasing net profit margins could indicate rising costs or inefficiencies, potentially impacting long-term profitability.

Cash Flow Challenges

Cash flow challenges may limit the company's ability to fund operations and growth, affecting financial health over time.

Negative Free Cash Flow Growth

Negative free cash flow growth suggests potential issues in cash generation, which could hinder future investments and expansion.

Pandox AB Business Overview & Revenue Model

Company Description

Pandox AB (publ) owns, operates, and leases hotel properties. The company operates through Property Management and Operator Activities segments. As of March 11, 2022, it operated 157 hotels with approximately 35,500 hotel rooms in 15 countries. The company was founded in 1932 and is based in Stockholm, Sweden.

How the Company Makes Money

Pandox AB generates revenue through multiple channels, with the primary revenue streams being rental income from leased hotels and management fees from operated properties. The company enters into long-term lease agreements with hotel operators, which provide a stable and predictable income source. Additionally, Pandox earns management fees from hotels it operates directly, which are typically based on a percentage of revenue or profit. The company also engages in property development and refurbishment projects, enhancing the value of its portfolio and generating additional income through increased property valuations. Strategic partnerships with well-known hotel brands and operators further bolster its revenue potential by attracting a diverse range of guests and optimizing occupancy rates across its properties.

Pandox AB Financial Statement Overview

Summary

Pandox AB demonstrates strong revenue growth and operational efficiency, as evidenced by healthy EBIT and EBITDA margins. However, declining net profit margins and cash flow challenges in the TTM period highlight areas for improvement. The balance sheet remains stable, but the company should focus on enhancing return on equity and cash flow generation to strengthen its financial position.

Income Statement

Pandox AB has shown consistent revenue growth, with a notable increase in the TTM period. The gross profit margin remains strong, indicating efficient cost management. However, the net profit margin has decreased in the TTM period, suggesting increased expenses or other financial pressures. The EBIT and EBITDA margins are robust, reflecting strong operational performance.

Balance Sheet

The company maintains a moderate debt-to-equity ratio, indicating a balanced approach to leveraging. However, the return on equity has declined, suggesting less efficient use of equity capital. The equity ratio is stable, showing a solid asset base relative to equity.

Cash Flow

Pandox AB's cash flow performance is mixed. The operating cash flow to net income ratio is below 1, indicating potential cash flow challenges. The free cash flow growth rate is negative in the TTM period, raising concerns about cash generation capabilities. However, the company has managed to maintain positive operating cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	7.29B	7.14B	6.88B	5.65B	3.27B	3.18B
Gross Profit	4.00B	3.85B	3.62B	3.10B	1.73B	1.61B
EBITDA	4.33B	3.96B	1.87B	4.36B	1.46B	-202.00M
Net Income	2.03B	1.69B	-585.00M	4.22B	610.00M	-1.41B
Balance Sheet
Total Assets	84.81B	80.69B	73.21B	75.22B	66.80B	64.81B
Cash, Cash Equivalents and Short-Term Investments	3.11B	1.29B	769.00M	1.63B	1.59B	2.62B
Total Debt	44.28B	38.70B	35.63B	37.09B	35.66B	34.38B
Total Liabilities	51.97B	46.99B	43.48B	44.28B	41.38B	40.73B
Stockholders Equity	32.65B	33.53B	29.57B	30.73B	25.21B	23.88B
Cash Flow
Free Cash Flow	634.00M	802.00M	1.27B	1.04B	-479.00M	-644.00M
Operating Cash Flow	1.88B	1.83B	2.19B	2.38B	430.00M	460.00M
Investing Cash Flow	-6.50B	-4.12B	-1.48B	-1.64B	-1.52B	-1.60B
Financing Cash Flow	6.31B	2.70B	-1.70B	-806.00M	93.00M	3.07B

Pandox AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 185.60
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:PNDX.B, the sentiment is Positive. The current price of 185.6 is below the 20-day moving average (MA) of 189.61, below the 50-day MA of 186.21, and above the 200-day MA of 173.60, indicating a neutral trend. The MACD of 0.34 indicates Positive momentum. The RSI at 46.73 is Neutral, neither overbought nor oversold. The STOCH value of 61.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:PNDX.B.

Pandox AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
WIHL	78 Outperform	kr28.28B	12.68	9.74%	3.57%	5.18%	349.60%
PNDX.B	67 Neutral	kr36.78B	18.14	6.23%	2.24%	2.86%	―
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
ATRLJ.B	65 Neutral	kr21.13B	19.39	3.82%	2.16%	-1.77%	1579.70%
HUFV.A	62 Neutral	kr24.34B	25.78	3.94%	2.24%	1.72%	―
SHOT	61 Neutral	€20.02B	27.01	21.87%	5.61%	1.45%	34.85%
FABG	54 Neutral	kr25.86B	90.41	0.76%	2.38%	-3.46%	―

Pandox AB Corporate Events

Pandox AB Reports Strong Q3 2025 Results and Strategic Acquisition

Pandox AB reported a solid financial performance for the third quarter of 2025, with a notable increase in revenues and net operating income across its leasing and own operations segments. The company announced a significant acquisition of Dalata Hotel Group plc, expected to enhance its portfolio with 31 new investment properties, potentially increasing its market value and profitability. This strategic move is anticipated to strengthen Pandox’s position in the hotel property market, particularly in the UK and Ireland, and is expected to yield substantial rental income, aligning with the company’s existing agreements.

The most recent analyst rating on ($SE:PNDX.B) stock is a Hold with a SEK190.00 price target. To see the full list of analyst forecasts on Pandox AB stock, see the SE:PNDX.B Stock Forecast page.

Pandox AB to Release Interim Report and Host Market Data Presentation

Pandox AB announced the release of its interim report for January to September 2025, scheduled for October 23, 2025. The report’s presentation will be followed by a webcasted conference featuring market data presentations on the international and Nordic hotel markets by independent experts. This event highlights Pandox’s commitment to transparency and provides stakeholders with valuable insights into market trends, potentially impacting the company’s strategic decisions and industry positioning.

The most recent analyst rating on ($SE:PNDX.B) stock is a Hold with a SEK190.00 price target. To see the full list of analyst forecasts on Pandox AB stock, see the SE:PNDX.B Stock Forecast page.

Pandox AB Advances in Dalata Acquisition with EU Clearance

Pandox AB has received EU Commission clearance for its acquisition of Dalata Hotel Group plc, marking a significant milestone towards completing the transaction. The acquisition, facilitated through a court-sanctioned scheme, is expected to close by early November 2025, pending final court approval, which could enhance Pandox’s market position in the hotel industry.

Pandox Completes Acquisition of Elite Hotel Frost Kiruna

Pandox AB has finalized the acquisition of Elite Hotel Frost Kiruna, integrating it into their business segment Leases as of September 30, 2025, with a transaction value of approximately MSEK 347. This acquisition strengthens Pandox’s position in the hotel property market, potentially enhancing their portfolio value and offering more opportunities for growth in Northern Europe.

The most recent analyst rating on ($SE:PNDX.B) stock is a Hold with a SEK190.00 price target. To see the full list of analyst forecasts on Pandox AB stock, see the SE:PNDX.B Stock Forecast page.

Pandox AB Moves Closer to Acquiring Dalata Hotel Group

Pandox AB announced that Dalata Hotel Group plc’s shareholders have approved all resolutions related to Pandox’s acquisition of Dalata’s entire share capital. This approval marks a significant step towards completing the acquisition, which is expected to be finalized by the end of November 2025, pending court sanction and other conditions. The acquisition is set to enhance Pandox’s position in the hotel industry, potentially impacting stakeholders by expanding its portfolio and market influence.

Pandox AB Forms Nomination Committee for 2026 AGM

Pandox AB has announced the formation of its nomination committee for the 2026 annual general meeting, consisting of representatives from its largest shareholders and the chairman of the board. This committee is responsible for proposing the composition of the board, with the proposals to be presented in the notice for the AGM scheduled for April 2026. This move is in line with the principles adopted at the 2025 AGM and reflects Pandox’s commitment to structured governance and stakeholder engagement.

The most recent analyst rating on ($SE:PNDX.B) stock is a Hold with a SEK180.00 price target. To see the full list of analyst forecasts on Pandox AB stock, see the SE:PNDX.B Stock Forecast page.